Innovacell (TSE:504A) EBITDA Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:504A Innovacell Inc TSE:504A
10 GF Score
Price 円453.00
View Full Analysis

What is Innovacell EBITDA Margin %?

Innovacell TSE:504A -7.93% 10 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSE:504A with a GF Score™ of 10/100. Among 939 Biotechnology companies, Innovacell ranks worse than 106496.17% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Innovacell's EBITDA for the three months ended in Dec. 2025 was 円-567.06 Mil. Innovacell's Revenue for the three months ended in Dec. 2025 was 円0.00 Mil. Therefore, Innovacell's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.

Innovacell  (TSE:504A) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Innovacell EBITDA Margin % Related Terms

Innovacell EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Innovacell's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovacell EBITDA Margin % Chart

Innovacell Annual Data
Trend Dec23 Dec24 Dec25
EBITDA Margin %
0.00 0.00 0.00

Innovacell Quarterly Data
Dec23 Dec24 Sep25 Dec25 Mar26
EBITDA Margin % 0.00 0.00 0.00 0.00 0.00

TSE:504A vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Innovacell's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovacell EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innovacell's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Innovacell's EBITDA Margin % falls into.


TSE:504A
10GF Score
Innovacell Inc TSE:504A
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innovacell EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Innovacell's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1932.648/0
= %

Innovacell's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-567.059/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Innovacell (TSE:504A) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Innovacell and its competitors. According to the industry distribution chart, Innovacell ranks #999999 out of 939 companies in the Biotechnology industry.
Is Innovacell's EBITDA Margin % too high?
Innovacell's current EBITDA Margin % is 0.00%. Based on the distribution chart, Innovacell ranks #999999 out of 939 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Innovacell has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Innovacell's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Innovacell ranks #999999 out of 939 companies for EBITDA Margin %. This places Innovacell in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Innovacell and its competitors. Innovacell's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovacell stock overvalued right now?
Innovacell (TSE:504A) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Innovacell's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Innovacell (TSE:504A), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovacell Business Description

Address 3-5-11 Kamiosaki, Meguro Villa Garden, 5th floor, Shinagawa-ku, Tokyo, JPN, 141-0021
Innovacell Inc is engaged in the development, manufacturing, and sale of regenerative medicine products for the treatment of conditions including fecal and urinary incontinence. Its activities include researching potential therapeutic candidates, developing formulations, and commercializing products in the markets. The company is working on the development and commercialization of the following three cell therapy pipelines targeting incontinence (fecal and urinary incontinence): ICEF15, ICEF16, and ICES13.
10GF Score

Get the complete analysis for TSE:504A

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円453.00
Price